Skip to content
Biodatica
Start free

INSTITUTE FOR SYSTEMS BIOLOGY

SEATTLE, WA

Oncologyliquid biopsyGrant-only
Compare Sign in to watch

What changed

NIH UG3 · $1.2M · Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Accelerating Translation to Health (GenePath)

5mo agoNew grantFeb 16, 2026Source filing (opens the source filing in a new tab)

Momentum

59no change

Momentum 59 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

10,139 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    UG3 · $1.2M · non-dilutive

    Feb 16, 2026

    VANDERBILT UNIVERSITY MEDICAL CENTER · PI EMBI, PETER J. · NHGRI · award ends Jan 31, 2028 · Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Accelerating Translation to Health (GenePath)

    NIH RePORTER · NIH RePORTER 11144748 (opens the source filing in a new tab)

  2. Grant

    R01 · $533k · non-dilutive

    Jan 1, 2025

    INSTITUTE FOR SYSTEMS BIOLOGY · PI WEI, WEI · NCI · award ends Dec 31, 2028 · RarecyteFinder: A Bench-to-Bits Toolkit for Label-Free, Whole-Spectrum Analysis of Rare Disseminated Tumor Cells in Liquid and Tissue Biopsies

    NIH RePORTER · NIH RePORTER 11252521 (opens the source filing in a new tab)

  3. Grant

    R01 · $852k · non-dilutive

    Jan 1, 2025

    VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · NIA · award ends Dec 31, 2029 · Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias

    NIH RePORTER · NIH RePORTER 11251781 (opens the source filing in a new tab)

  4. Grant

    R01 · $518k · non-dilutive

    Mar 1, 2024

    UNIVERSITY OF CHICAGO · PI WEI, WEI · NEI · award ends Jan 31, 2029 · Dynamic interactions between synaptic and intrinsic properties of starburst amacrine cells for robust motion detection

    NIH RePORTER · NIH RePORTER 11261140 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources